Clinical Trials on Transitional Cell Carcinoma in France

Total 5181 results

Peplin

Completed

To Determine the Maximum Tolerated Dose Level (MTD) of PEP005 Topical Gel in Patients With sBCC

Superficial Basal Cell Carcinoma

United States
Centre Georges Francois Leclerc

Recruiting

Study Evaluating the Safety and the Efficacy of Combination of Atezolizumab, Tiragolumab and and Stereotactic Body Radiation Therapy in Patients With Oligometastatic Multiorgan (IMMUNOs-SBRT) (IMMUNOs-SBRT)

Metastatic Renal Cell Carcinoma | Metastatic Non Small Cell Lung Cancer | Metastatic Head and Neck Cancer | Metastatic Bladder Cancer

France
InflaRx GmbH
Merck Sharp & Dohme LLC

Active, not recruiting

Non-comparative Study of IFX-1 Alone or IFX-1+Pembrolizumab in Patients With Locally Advanced or Metastatic cSCC.

SCC - Squamous Cell Carcinoma of Skin

United States, Spain, Germany, Belgium, France
Centre Henri Becquerel

Recruiting

Dynamics of 18-FDG Uptake in Stage III/IV Non Small Cell Lung Cancer During First Line Pembrolizumab Treatment (iTEP1)

Non Small Cell Lung Cancer

France
Centre Hospitalier Universitaire de Nīmes
MEDEXPRIM; GRATICULE

Completed

Predicting Response to PD-1 Checkpoint Blockade Using Deep Learning Analysis of Imaging and Clinical Data (Onc AI)

Non-small Cell Lung Cancer (NSCLC)

France
Centre Henri Becquerel
Intergroupe Francophone de Cancerologie Thoracique

Unknown

Study of Interest of Personalized Radiotherapy Dose Redistribution in Patients With Stage III NSCLC (RTEP7)

Non-small Cell Lung Cancer

France
Regeneron Pharmaceuticals
Sanofi

Active, not recruiting

Study of REGN 2810 Compared to Platinum-Based Chemotherapies in Participants With Metastatic Non-Small Cell Lung Cancer (NSCLC)

Nonsmall Cell Lung Cancer | Carcinoma，Non-Small-Cell Lung | Non-small-cell Lung Carcinoma | Lung Carcinomas, Non-Small-Cell

Spain, Australia, Belarus, Brazil, Bulgaria, Chile, China, Colombia, Czechia, Georgia, Greece, Hungary, Jordan, Lebanon, Malaysia, Mexico, Philippines, Poland, Romania, Russian Federation, Taiwan, Thailand, Turkey, Ukraine
Inhibrx, Inc.

Recruiting

INBRX-106 in Combination With Pembrolizumab in First-line PD-L1 CPS≥20 HNSCC

Head and Neck Squamous Cell Carcinoma (HNSCC)

United States
Assistance Publique Hopitaux De Marseille

Terminated

Phase I Multicenter Trial Combining Nivolumab, Ipilimumab and Hypo-fractionated Radiotherapy for Pretreated Advanced Stage Non-small Cell Lung Cancer Patients

Non-small Cell Lung Cancer

France
Poitiers University Hospital
Institut National de la Santé Et de la Recherche Médicale, France

Completed

Prognostic PET/CT Model in Non Small Cell Lung Cancer

Non Small Cell Lung Cancer

France
Onconova Therapeutics, Inc.

Completed

Oral Rigosertib for Squamous Cell Carcinoma

Head and Neck Squamous Cell Carcinoma | Esophageal Squamous Cell Carcinoma | Anal Squamous Cell Carcinoma | Cervical Squamous Cell Carcinoma | Skin Squamous Cell Carcinoma | Lung Squamous Cell Carcinoma | Penile Squamous Cell Carcinoma

United States
Centre Antoine Lacassagne

Recruiting

18FDG PET for Early Identification of Tumor Exhaust for Immunotherapy in Patients With Locally Advanced or Metastatic Non-Small Cell Bronchopulmonary Carcinoma or Melanoma (FDG-IMMUN)

Non-Small Cell Bronchopulmonary Carcinoma or Melanoma

France
Centre Hospitalier Régional Universitaire Montpellier

Completed

Pulmonary Function After Arterial Sleeve Lobectomy

Lung Cancer, Nonsmall Cell

France
Centre Oscar Lambret
Roche Pharma AG

Completed

Study About Preventive Treatment of Folliculitis Induced by Epidermal Growth Factor Receptor Inhibitors (DIPROCOL)

Metastatic Colorectal Cancer | Non-Small-Cell Lung Carcinoma

France
National Cancer Institute (NCI)

Recruiting

Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors

Stage IV Renal Cell Cancer AJCC v8 | Sarcomatoid Renal Cell Carcinoma | Stage IV Bladder Cancer AJCC v8 | Stage IV Urethral Cancer AJCC v8 | Stage IVB Prostate Cancer AJCC v8 | Bladder Adenocarcinoma | Chromophobe Renal Cell Carcinoma | Papillary Renal Cell Carcinoma | Collecting Duct Carcinoma | Bladder... and other conditions

United States, Puerto Rico
European Organisation for Research and Treatment...
Merck KGaA, Darmstadt, Germany

Recruiting

Radiotherapy Plus Xevinapant in Older Patients With Locally Advanced Head and Neck Squamous Cell Carcinoma (RAVINA)

Locally Advanced Head and Neck Squamous Cell Carcinoma

France, Belgium, Netherlands, Norway, United Kingdom, Ireland, Italy, Slovenia, Germany, Spain
Centre Hospitalier Universitaire, Amiens
Groupe Hospitalier Pitie-Salpetriere

Recruiting

Study of the Relationship Between Clinical, Imaging and Biological Data in Patients With Squamous Cell Carcinoma of the Tongue (ClimaBio)

Squamous Cell Carcinoma | Proton Magnetic Resonance Spectroscopy | Transcriptomics | Soft Tissue Tumors of the Tongue

France
Assistance Publique - Hôpitaux de Paris
Institut National de la Santé Et de la Recherche Médicale, France; FONCER contre...

Recruiting

Biomarkers of Angiogenesis for Response to Therapeutic Combination in Advanced or Metastatic Kidney Cancer (ANGIOCOR)

Renal Cell Carcinoma | Renal Cancer | Renal Cancer Metastatic

France
University Hospital, Angers
Vitaflo International, Ltd

Recruiting

Ketogenic Diet for Patients Receiving First Line Treatment for Metastatic Renal Cell Carcinoma (CETOREIN)

Metastatic Renal Cancer

France
Hospices Civils de Lyon

Completed

Three Modalities of Treatment in Operable and Resectable Stage IIIA (T1-3, N2) Non-Small Cell Lung Cancer (NSCLC)

Non-small Cell Lung Cancer

France
University Hospital, Toulouse

Recruiting

A Machine Learning Approach to Identify Patients With Resected Non-small-cell Lung Cancer With High Risk of Relapse (MIRACLE)

Non-small Cell Lung Cancer Stage IIIA

France
Centre Leon Berard
Boehringer Ingelheim

Completed

Evaluation of Afatinib in Maintenance Therapy in Squamous Cell Carcinoma of the Head and Neck (BIBW2992ORL)

Head and Neck Squamous Cell Carcinoma

France
Bristol-Myers Squibb

Active, not recruiting

Non-Interventional Study (NIS) of Nivolumab With or Without Ipilimumab in Participants With Advanced Kidney Cancer (WITNESS)

Kidney Cancer | Renal Cell Carcinoma | Renal Cell Cancer | Adenocarcinoma Of Kidney | Adenocarcinoma, Renal Cell | Cancer of the Kidney

France
Centre Hospitalier Universitaire de Saint Etienne

Completed

Comparison of 3 in Vivo Microscopic Imaging Techniques for the Diagnosis of Pigmented Tumors (Micro3)

Melanoma | Nevus | Lentigo | Basal Cell Carcinoma | Seborrheic Keratosis | Lentigo Maligna

France
University of Colorado, Denver
Genentech, Inc.

Suspended

Radiotherapy in Combination With Atezolizumab Prior to Surgical Resection for HPV Unrelated HNSCC

Squamous Cell Carcinoma of Head and Neck

United States
Gustave Roussy, Cancer Campus, Grand Paris

Unknown

Double-blind, Placebo-controlled, Randomized Study of the Effectiveness of Escitalopram on Emotional Distress of Head and Neck Cancer Patients During Cancer Treatment

Carcinomas

France
Nektar Therapeutics
Bristol-Myers Squibb

Completed

A Dose Escalation and Cohort Expansion Study of NKTR-214 in Combination With Nivolumab and Other Anti-Cancer Therapies in Patients With Select Advanced Solid Tumors (PIVOT-02)

Melanoma | Renal Cell Carcinoma | Gastric Cancer | Non Small Cell Lung Cancer | Triple Negative Breast Cancer | Urothelial Carcinoma | HR+/HER2- Breast Cancer

United States, Spain, Canada, France, Italy, Belgium, Poland, United Kingdom
Hospices Civils de Lyon

Recruiting

CANPOS: Predictive Biomarkers of Tumor Progression in Non-small Cell Lung Cancer (CANPOS)

Non-small Cell Lung Cancer

France
Gustave Roussy, Cancer Campus, Grand Paris

Terminated

A Phase II Study of Velcade® in Patients Stage IIIB OR IV Non-Small Cell Lung Cancer

STAGE IIIB OR IV NON-SMALL CELL LUNG CANCER

France
Gustave Roussy, Cancer Campus, Grand Paris
Novartis

Unknown

Study to Evaluate RAD001 in Combination With Radiotherapy in Non-small Cell Lung Cancer (RAD001)

Non-small Cell Lung Cancer | Locally Advanced Disease

France
University Hospital, Grenoble

Withdrawn

cDC1 Prognostic and Predictive Role in Non-Small-Cell Lung Cancer Patients Receiving Immune Checkpoint Inhibitors (LUNG-PREDICT)

Non Small Cell Lung Cancer

France
Centre Hospitalier Universitaire Dijon

Not yet recruiting

Pilot Study of the Contribution of Fractional Exhaled Nitric Oxide as a Prognostic Marker of Response to Anti-PD-L1 Immunotherapy in Non-small Cell Lung Cancer (FENOTYPE)

Metastatic Non-small Cell Lung Cancer

France
University Hospital, Brest

Recruiting

Retrospective Observational Study on Prediction of Response to PD-1 Immunotherapy in Patients With NSCLC (PREDICTION)

Advanced Non Small Cell Lung Cancer

France
Assistance Publique Hopitaux De Marseille

Active, not recruiting

Precision Immuno-Oncology for Advanced Non-small Cell Lung Cancer Patients With PD-1 ICI Resistance (PIONeeR-BioMarkers (BM) Profiling) (PIONeeR)

Non-small Cell Lung Cancer Patients

France
Hospices Civils de Lyon

Completed

IFCT-GFPC 05.02 A Randomized Phase III Trial Assessing in Patients With Advanced Non-small Cell Lung Cancer

Stage IV Non-small Cell Lung Cancer

France
Association Pour La Recherche des Thérapeutiques...

Completed

A BIOmarker Driven Trial With Nivolumab and Ipilimumab or VEGFR tKi in Naïve Metastatic Kidney Cancer (BIONIKK)

Clear Cell Metastatic Renal Cell Carcinoma

France
Calliditas Therapeutics Suisse SA

Active, not recruiting

A Study of Setanaxib Co-Administered With Pembrolizumab in Patients With Recurrent or Metastatic Squamous Cell Carcinoma of Head and Neck (SCCHN)

Squamous Cell Carcinoma of Head and Neck

Spain, France, United States, Germany, Italy, Poland, United Kingdom
Association Pour La Recherche des Thérapeutiques...

Unknown

Dose-finding, Safety and Efficacy Study of Radium-223 Dichloride (XOFIGO) in RCC Patients With Bone Metastases. (EIFFEL) (EIFFEL)

Bone Metastases | Clear-cell Metastatic Renal Cell Carcinoma

France
University Hospital, Angers

Not yet recruiting

PEMBRO-K : Evaluation of Pembrolizumab Therapeutic Pharmacological Monitoring Benefit in NSCLC (PEMBRO-K)

Non Small Cell Lung Cancer

France
University Hospital, Angers

Unknown

SCLC on the 2nd Line With Relapsed After Response to Chemotherapy GFPC 01-2013 (CBPC)

Small Cell Lung Cancer

France
Intergroupe Francophone de Cancerologie Thoracique
Novartis

Completed

RW Effectiveness of Capmatinib in Advanced MET-dysregulated NSCLC Included in the French Compassionate Use Program (ATU) (CapmATU)

Non Small Cell Lung Cancer | MET Alterations | METex14 Mutations

France
Centre Paul Strauss

Unknown

Study of the Decrease of Length of Stereotactic Body Radiation Therapy in Lung Cancer (PNEUMOFRAC)

Stage IA - IB Non Small Cell Lung Cancer

France
Rennes University Hospital
Roche Pharma AG

Completed

Molecular Diagnosis on Circulating Tumor DNA of Non-Small Cell Lung Cancer (ANTiCIPe)

Stage IIIb and IV Non Small Cell Lung Cancer

France
Assistance Publique - Hôpitaux de Paris

Completed

Effect of Low Molecular Weight Heparin: Tinzaparin in Lung Tumours (TILT) (TILT)

Lung Cancer | Non Small Cell Lung Cancer

France
Hospices Civils de Lyon

Recruiting

Evaluation of a Novel Microfluidic Device to Purify Metastatic Lung Cancer Patients CTC (Circulating Tumoral Cells) (LUTON)

Non Small Cell Lung Cancer

France
Institut Claudius Regaud
University Hospital, Bordeaux

Completed

Therapeutic Drug Monitoring of Sunitinib and Pazopanib in Advanced or Metastatic Renal Cell Carcinoma (SUP-R)

Metastatic Renal Cell Cancer

France
Eli Lilly and Company

Terminated

A Study of LY2584702 With Erlotinib or Everolimus in Participants With Solid Tumors

Renal Cell Carcinoma | Metastases, Neoplasm | Neuroendocrine Tumors | Carcinoma, Non-small Cell Lung

France, United States
Hospices Civils de Lyon

Recruiting

Radio/Pathological Evaluation of Tongue Cancer Infiltration (RaP E ToC)

Cell Carcinoma | Oral Squamous

France
Centre Leon Berard

Completed

Axitinib in1st Line Treatment for Patients With Advanced or Metastatic Papillary Renal Cell Carcinoma (AXIPAP)

Papillary Renal Cell Carcinoma

France
GERCOR - Multidisciplinary Oncology Cooperative...
Pfizer; Ipsen

Unknown

A Study of Sunitinib Versus Placebo in Combination With Lanreotide in Patients With Progressive Advanced/Metastatic Midgut Carcinoid Tumors (SUNLAND)

Carcinoid Tumors

France, Belgium

Clinical Trials on Transitional Cell Carcinoma in France

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Portugal

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations